# ReIMAGINE Prostate Cancer Screening

> **NCT04063566** · NA · COMPLETED · sponsor: **University College, London** · enrollment: 309 (actual)

## Conditions studied

- Prostate Cancer Screening
- Prostate Cancer

## Interventions

- **PROCEDURE:** Magnetic Resonance Imaging (MRI)
- **PROCEDURE:** Prostate-specific antigen (PSA) test

## Key facts

- **NCT ID:** NCT04063566
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-21
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04063566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04063566, "ReIMAGINE Prostate Cancer Screening". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04063566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*